Session Details

[27-05-am]ADME, PK/PD, Drug Interactions, etc.

Thu. Mar 27, 2025 10:20 AM - 11:32 AM JST
Thu. Mar 27, 2025 1:20 AM - 2:32 AM UTC
Room 5 (Fukuoka International Congress Center: 202 [2F])
Chair: Kazutaka Oda, Sai Yasukochi

[27-05-am09S]Development of a new in silico mathematical model coupled with in vitro BE checker to predicting oral pharmacokinetic profiles of drugs in humans.

○Takuto Niino1, Toshihide Takagi2, Hiroyuki Yoshida3, Shinji Yamashita4,5, Atsushi Kambayashi1 (1. Faculity of Pharmaceutical Sciences, Tokyo University of Science, 2. Faculity of Pharmaceutical Sciences, Setsunan University, 3. National Institute of Health Sciences, 4. Institute of Comprehensive Science and Engineering, Ritsumeikan University , 5. iBET Firm)

[27-05-am10S]Elucidation of the effect of Lactic acid bacteria-derived extracellular vesicles on the intestinal immune system and formulation for oral administration

○Yuta Yamawaki1, Masaki Morishita1, Yusuke Kono1, Kenichi Ogawara1 (1. Grad. Sch. Pharm. sci., kobepharma Univ)

[27-05-am11]Metabolo-proteomics approach for clarifying mechanism underlying resistance against antitumor effect of ribavirin

○Masashi Kawami1, Airi Fukushima1, Ryoko Yumoto1, Mikihisa Takano2, Yasuo Uchida1 (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 2. Sch. Pharm. Sci., Yasuda Women's Univ.)

[27-05-am12S]Development of a simultaneous quantification method for linezolid and its metabolites using HPLC-UV

○Kanae Someya1, Fumihiro Kurosaki1, Shiori Sumi1, Hitoshi Kawasuji2, Naoki Oikawa1, Takahiko Aoyama1, Yoshihiro Yamamoto2, Taketo Uchiyama1, Tsuji Yasuhiro1 (1. Sch. Pharm., Nihon Univ., 2. Fac. Med., Toyama Univ.)

[27-05-am13S]Evaluation of anti-PEG immune responses in young mice intravenously injected with PEGylated liposomes

○Hina Naruoka1, Hidenori Ando1,2, Haruka takata1,2, Taro Shimizu3, Tatsuhiro Ishida1,2 (1. Pharm. Sci., Tokushima Univ., 2. iDDS, Tokushima Univ., 3. BIKEN, Osaka Univ.)

[27-05-am14]Application of Chronotherapy with xCT Inhibitors and the Potential for Combination Therapy via Oxidative Stress Induction

○fumiyasu okazaki1,2, Yusaku Takamura1, Kenji Tabata1, Takaaki Komatsu1, Yasuhiro Tsuji2,3, Hideto To2 (1. Daiichi Univ. Pharm., 2. Grad. Sch.Pharm. Toyama Univ., 3. Grad. Sch.Pharm. Nihon Univ.)